2-(4-(Benzo[c][1,2,5]thiadiazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-pyrazol-1-yl)-N-(3-cyanophenyl)acetamide

ID: ALA4522374

PubChem CID: 155543087

Max Phase: Preclinical

Molecular Formula: C24H17N7OS

Molecular Weight: 451.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(-c2c(-c3ccc4nsnc4c3)cnn2CC(=O)Nc2cccc(C#N)c2)n1

Standard InChI:  InChI=1S/C24H17N7OS/c1-15-4-2-7-21(27-15)24-19(17-8-9-20-22(11-17)30-33-29-20)13-26-31(24)14-23(32)28-18-6-3-5-16(10-18)12-25/h2-11,13H,14H2,1H3,(H,28,32)

Standard InChI Key:  DULCROIFJWJPCW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   30.0216   -4.9425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4187   -4.6494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9076   -2.9978    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   30.5358   -7.3616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8964   -3.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0825   -3.4893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4130   -5.4930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8063   -5.1968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5792   -6.3004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4011   -2.3285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.3902   -3.6709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3640   -6.5547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6368   -4.1034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9826   -6.0014    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1804   -3.4228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2255   -4.8173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3302   -3.8293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6130   -2.5901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1871   -2.5937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8947   -2.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6158   -3.4206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6323   -5.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4576   -5.5296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8679   -6.2456    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.8724   -4.8162    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6932   -6.2482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1000   -6.9674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9245   -6.9703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3402   -6.2564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9254   -5.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1022   -5.5385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3345   -7.6853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7445   -8.4015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
 15  5  1  0
 10  3  1  0
 15 19  1  0
  2 16  1  0
  2  8  1  0
  9 12  1  0
 17  2  2  0
 12 14  2  0
 16 13  1  0
  8  1  2  0
 12  4  1  0
 13  6  2  0
  8 14  1  0
  6 17  1  0
  7  9  2  0
 19 10  2  0
 20 19  1  0
 11 15  2  0
  3 11  1  0
 18 20  2  0
  1  7  1  0
  5 21  2  0
 21 17  1  0
 21 18  1  0
 16 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 32 33  3  0
 28 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4522374

    ---

Associated Targets(Human)

TGFBR1 Tchem TGF-beta receptor type I (3786 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.52Molecular Weight (Monoisotopic): 451.1215AlogP: 4.44#Rotatable Bonds: 5
Polar Surface Area: 109.38Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.96CX Basic pKa: 4.28CX LogP: 3.83CX LogD: 3.83
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: -2.25

References

1. Zhu WJ, Cui BW, Wang HM, Nan JX, Piao HR, Lian LH, Jin CH..  (2019)  Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives.,  180  [PMID:31299584] [10.1016/j.ejmech.2019.07.013]

Source